Table 2 Baseline characteristics comparison within Cohort 2 (PP vs MD groups)
Characteristic | Cohort 2 (PP) N = 103 | Cohort 2 (MD) N = 33 | P value |
|---|---|---|---|
Age, (years) mean ± SD | 66 ± 9.1 | 65 ± 6.2 | NS |
Male gender, N (%) | 69 (67%) | 26 (79%) | NS |
Weight, (kg) mean ± SD | 87 ± 20.8 | 97 ± 23.9 | < 0.035 |
BMI, (kg/m2) mean ± SD | 30.3 ± 6.2 | 32 ± 7.6 | NS |
Diabetes type, N (%) | |||
- Type 1 | 8 (7.8%) | 2 (6.1%) | NS |
- Type 2 | 90 (87.4%) | 30 (90.9%) | NS |
- Unknown | 5 (4.9%) | 1 (3%) | NS |
Diabetes therapy, N (%) | |||
- Insulin | 39 (37.9%) | 23 (69.7%) | < 0.002 |
- Oral therapy | 57 (55.3%) | 9 (27.3%) | NS |
BGL, (mmol/L) | |||
- Mean ± SD | 14.2 ± 2.7 | 14.8 ± 2.3 | NS |
- Range | 10.4–24.3 | 10.4–19.5 | |